Search company, investor...

Predict your next investment

St. Jude Medical company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
sjm.com

Investments

13

Portfolio Exits

3

Partners & Customers

10

Service Providers

1

About St. Jude Medical

St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological, and chronic pain patients worldwide.

Headquarters Location

1 St. Jude Medical Dr

Saint Paul, Minnesota, 55117,

United States

651-756-2000

Want to inform investors similar to St. Jude Medical about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing St. Jude Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find St. Jude Medical in 2 Expert Collections, including Medical Devices.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

D

Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest St. Jude Medical News

Structural Heart Devices Market will grow to USD 31.7 billion by 2030 : GreyViews

Jan 27, 2023

Major Players Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Abbott Laboratories, ST. JUDE MEDICAL, Biomerics, Comed BV, LivaNova PLC, JenaValve Technology Inc., and CardioKinetix. among others Segmentation Analysis Aortic valvular disease is expected to be the fastest-growing segment in 2022. The indication segment is divided into atrial septal defects, aortic valvular disease, pulmonary valvular disease, patent foramen ovale, ventricular septal defects, mitral valvular disease, patent ductus arteriosus, and others. The aortic valvular disease segment is expected to witness the highest growth rate during the forecast period. There is a connection between aortic valvular disease and the aorta, since the aorta carries oxygenated blood from the heart to the body, and when there is aortic valvular disease, the aorta does not fully open. In order to treat it, a structural cardiac device is implanted through minimally invasive surgical techniques. Therefore, the indication section will be dominated by aortic valvular disease. Heart valve devices are expected to be the fastest-growing segment in 2022. The product type segment is divided into heart valve devices, annuloplasty rings, occluders and delivery systems, transcatheter mitral valve repair, and others. The heart valve devices segment is expected to witness the highest growth rate during the forecast period. It is a one-way valve implanted into the heart as a replacement for a heart valve that does not function properly. A mechanical heart valve, a bioprosthetic tissue valve or an engineered tissue valve are three broad categories of artificial heart valves. Replacement is expected to be the fastest-growing segment in 2022. The procedure segment is divided into repair and replacements. The replacement segment is expected to witness the highest growth rate during the forecast period. As a result of the development of superior, flexible, sophisticated, resilient, and highly effective structural cardiac devices, the need for replacement has increased. A successful long-term alternative to repair methods is a replacement, which increases blood flow and makes the patient live a longer life. Regional Analysis            The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the structural heart devices market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North American region witnessed a major share. Structural heart devices have been a major success in North America due to a large pool of patients, favourable reimbursement scenarios, and advanced healthcare infrastructure. Although minimally invasive surgery such as transcatheter aortic valve implantation (TAVI) and mitral valve repair/replacement may reduce utilization rates over the forecast period, increasing penetration may result in lower utilization rates. Country Analysis Germany Germany's structural heart devices market size was valued at USD 0.92 billion in 2022 and is expected to reach USD 2.18 billion by 2030, at a CAGR of 11.4% from 2023 to 2030. In Germany, the market is expanding due to an increase in surgeries, cardiovascular illnesses, and advanced treatment methods. China China’s structural heart devices market size was valued at USD 0.98 billion in 2022 and is expected to reach USD 2.37 billion by 2030, at a CAGR of 11.7% from 2023 to 2030. As awareness of cardiac disease increases, neonatal screening programs improve, and access to healthcare expands in China, the market is expected to expand. India India's structural heart devices market size was valued at USD 0.76 billion in 2022 and is expected to reach USD 1.8 billion by 2030, at a CAGR of 11.6% from 2023 to 2030. Increasing healthcare facility demand, a favourable reimbursement environment, and an increase in structural heart disease awareness drive the market for structural heart devices in the country. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of this market is mainly driven owing to the rising demand for flavored beverages among consumers, propelling the growth of the market across the countries. Buy Now Full Report @ https://greyviews.com/checkout/467/single_user_license Contact Us Browse Related Reports: Veterinary Hematology Analyzers Market Size By Product Type (Table Top Analyzers (Fully Automatic Analyzers and Semiautomatic Analyzers) and Point of Care Analyzers (Cartridge-Based Analyzers and Direct Sample Based Analyzers), By Analysis Parameter (2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBC Differential, and Others), By End-User (Research institutes, Veterinary hospitals and clinics, Veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others), Regions, Segmentation, and Projection till 2030 Structural Heart Devices Market Size By Indication (Atrial Septal Defects, Aortic Valvular Disease, Pulmonary Valvular Disease, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Valvular Disease, Patent Ductus Arteriosus, and Others), By Product Type (Heart Valve Devices, Annuloplasty Rings, Occluders and Delivery Systems, Transcatheter Mitral Valve Repair, and Others), By Procedure(Repair and Replacements), Regions, Segmentation, and Projection till 2030  Shoulder Arthroplasty Market Size By Indication (Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Others), By Device (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), By Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Regions, Segmentation, and Projection till 2030

St. Jude Medical Investments

13 Investments

St. Jude Medical has made 13 investments. Their latest investment was in Spinal Modulation as part of their Corporate Minority on June 6, 2013.

CBI Logo

St. Jude Medical Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/11/2013

Corporate Minority

Spinal Modulation

$40M

Yes

2

5/6/2011

Series C

iRhythm Technologies

$15M

No

9/17/2010

Corporate Minority

CardioMems

$60M

No

1

5/21/2010

Series B

Subscribe to see more

$99M

Subscribe to see more

0

5/19/2010

Series G

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/11/2013

5/6/2011

9/17/2010

5/21/2010

5/19/2010

Round

Corporate Minority

Series C

Corporate Minority

Series B

Series G

Company

Spinal Modulation

iRhythm Technologies

CardioMems

Subscribe to see more

Subscribe to see more

Amount

$40M

$15M

$60M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

0

0

St. Jude Medical Portfolio Exits

3 Portfolio Exits

St. Jude Medical has 3 portfolio exits. Their latest portfolio exit was iRhythm Technologies on October 20, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/20/2016

IPO

$99M

Public

12

10/19/2016

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

11/14/2007

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/20/2016

10/19/2016

11/14/2007

Exit

IPO

Divestiture

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

12

10

0

St. Jude Medical Acquisitions

14 Acquisitions

St. Jude Medical acquired 14 companies. Their latest acquisition was Thoratec on July 22, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/22/2015

$99M

Acq - P2P

1

4/20/2015

Other

$99M

$106.9M

Acquired

1

8/7/2014

$99M

Acquired

2

6/2/2014

Other

Subscribe to see more

$99M

$99M

Subscribe to see more

10

10/15/2013

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

7/22/2015

4/20/2015

8/7/2014

6/2/2014

10/15/2013

Investment Stage

Other

Other

Series C

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$106.9M

$99M

$99M

Note

Acq - P2P

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

St. Jude Medical Partners & Customers

10 Partners and customers

St. Jude Medical has 10 strategic partners and customers. St. Jude Medical recently partnered with Chalice Medical on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/12/2021

Partner

United Kingdom

1

9/27/2018

Partner

Switzerland

World Health Organization, St. Jude Children's Research Hospital collaborate against childhood...

MEMPHIS , Tenn. , Sept. 27 , 2018 / PRNewswire / -- St. Jude today announced a five-year collaboration with World Health Organization aimed at transforming cancer care worldwide to cure at least 60 percent of children with six of the most common types of cancer by 2030 .

2

6/5/2018

Partner

United States

1

12/18/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

11/21/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

10/12/2021

9/27/2018

6/5/2018

12/18/2017

11/21/2017

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

United Kingdom

Switzerland

United States

United States

United States

News Snippet

World Health Organization, St. Jude Children's Research Hospital collaborate against childhood...

MEMPHIS , Tenn. , Sept. 27 , 2018 / PRNewswire / -- St. Jude today announced a five-year collaboration with World Health Organization aimed at transforming cancer care worldwide to cure at least 60 percent of children with six of the most common types of cancer by 2030 .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

St. Jude Medical Service Providers

1 Service Provider

St. Jude Medical has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Sole Financial Advisor

Service Provider

Associated Rounds

Acq - P2P

Provider Type

Investment Bank

Service Type

Sole Financial Advisor

Partnership data by VentureSource

St. Jude Medical Team

20 Team Members

St. Jude Medical has 20 team members, including , .

Name

Work History

Title

Status

Manny Villafaña

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Manny Villafaña

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.